Drug Approval | September 06, 2021
             
           Accutest enables NMPA approval for Qilu’s Abiraterone
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
 
        Subscribe To Our Newsletter & Stay Updated